A new study by drugmaker GlaxoSmithKline has found that Advair (fluticasone propionate, salmeterol) and Flovent (fluticasone propionate) appear to be safe for adults with asthma to use twice a day. Researchers found that both drugs were well tolerated when patients used them twice-daily during a 4-week trial, with no reports of serious side effects.
Read moreA cure for asthma is not likely. That's the bad news. The good news is that asthma deaths have decreased and advances in... Read more »
How will asthma care and health be affected by the economy?It is clear that we are in the midst of difficult economic times. Some of us can... Read more »
The American Academy of Neurology 60th Annual Meeting brought news of a new Alzheimer's drug called Dimebon. The drug just made it through... Read more »
The FDA just released its first quarterly report of drugs with "potential safety issues." A discussion of the concept is posted at FDA to... Read more »
After past blogs about alcohol and sex in relation to teens and diabetes, we now come to the next element that teens face: drugs. As far... Read more »
Patients whose asthma is not controlled by taking fluticasone propionate (Flovent) alone may benefit from taking antileukotriene drugs with the... Read more »
This is a study to compare the effects of Flovent (fluticasone propionate), Advair (fluticasone propionate/salmeterol), and Singulair (montelukast)... Read more »
Have questions or comments? Click here. Last week the Food and Drug Administration (FDA) listened to presentations and comments from several members... Read more »
This is a study to measure the asthma control of Flovent (fluticasone propionate) and salmeterol in children and teens whose asthma is worsened by... Read more »
GlaxoSmithKline is conducting a clinical trial to see if fluticasone propionate plus salmeterol (Advair) is better than fluticase propionate alone... Read more »